Literature DB >> 21314808

Increased arterial stiffness in mildly-hypertensive women with polycystic ovary syndrome.

Aiko Sasaki1, Yayoi Emi, Miwa Matsuda, Yasuhiko Kamada, Chebib Chekir, Yuji Hiramatsu, Mikiya Nakatsuka.   

Abstract

AIM: Although risk factors for cardiovascular disease, such as obesity, hyperinsulinemia, and dyslipidemia, are commonly observed in women with polycystic ovary syndrome (PCOS), impairment of vascular function is still controversial. We evaluated the vascular function in young women with PCOS.
METHODS: We evaluated arterial stiffness in 54 women with PCOS and 24 healthy control women using a volume-plethysmographic apparatus equipped with a multi-element applanation tonometry sensor for the left common carotid artery and studied the correlations of various factors.
RESULTS: There was no significant difference in age or body mass index between the controls and the women with PCOS. These women with PCOS had a significantly higher serum testosterone and C-reactive protein levels and showed insulin resistance and dyslipidemia. The mean blood pressure in women with PCOS was within the normal range, but still significantly higher than those in the controls. Women with PCOS had a significantly higher brachial-ankle pulse wave velocity (baPWV) than that for the controls (P < 0.02), whereas there was no significant difference in the carotid augmentation index between the two groups. Stepwise multiple regression analysis revealed that blood pressure influences the baPWV in women with PCOS. Arterial stiffness evaluated using the baPWV in mildly-hypertensive women (systolic blood pressure ≥120 mmHg or diastolic blood pressure ≥90 mmHg) with PCOS was significantly higher than that in the controls or normotensive women with PCOS.
CONCLUSIONS: Early changes in vascular function were detected in mildly-hypertensive women with PCOS. Lifestyle interventions to prevent hypertension, such as diet and exercise, should be the first-line of treatment in women with PCOS.
© 2011 The Authors. Journal of Obstetrics and Gynaecology Research © 2011 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Year:  2011        PMID: 21314808     DOI: 10.1111/j.1447-0756.2010.01375.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  6 in total

Review 1.  Sex differences in mechanisms of arterial stiffness.

Authors:  Jennifer J DuPont; Rachel M Kenney; Ayan R Patel; Iris Z Jaffe
Journal:  Br J Pharmacol       Date:  2019-05-11       Impact factor: 8.739

2.  Association of sex hormones with carotid artery distensibility in men and postmenopausal women: multi-ethnic study of atherosclerosis.

Authors:  Dhananjay Vaidya; Sherita H Golden; Nowreen Haq; Susan R Heckbert; Kiang Liu; Pamela Ouyang
Journal:  Hypertension       Date:  2015-03-09       Impact factor: 10.190

3.  Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome.

Authors:  Kara S Hughan; Hala Tfayli; Julia G Warren-Ulanch; Emma Barinas-Mitchell; Silva A Arslanian
Journal:  J Pediatr       Date:  2015-11-03       Impact factor: 4.406

4.  Brachial-to-ankle pulse wave velocity as an independent prognostic factor for ovulatory response to clomiphene citrate in women with polycystic ovary syndrome.

Authors:  Toshifumi Takahashi; Hideki Igarashi; Shuichiro Hara; Mitsuyoshi Amita; Koki Matsuo; Ayumi Hasegawa; Hirohisa Kurachi
Journal:  J Ovarian Res       Date:  2014-07-10       Impact factor: 4.234

5.  Cardiovascular Risk According to Body Mass Index in Women of Reproductive Age With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Chenchen Zhuang; Xufei Luo; Wenjuan Wang; Runmin Sun; Miaomiao Qi; Jing Yu
Journal:  Front Cardiovasc Med       Date:  2022-02-16

6.  Cardiovascular Risk in Women With PCOS.

Authors:  Pietro Scicchitano; Ilaria Dentamaro; Rosa Carbonara; Gabriella Bulzis; Annamaria Dachille; Paola Caputo; Roberta Riccardi; Manuela Locorotondo; Cosimo Mandurino; Marco Matteo Ciccone
Journal:  Int J Endocrinol Metab       Date:  2012-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.